Research Article
The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland
Table 1
Sociodemographic characteristics and clinical data of psoriasis patients and control group.
| |
Characteristics | Psoriasis |
Control
( = 30) | | Total
( = 61) | Arthritis
( = 22) | Without arthritis
( = 39) | Psoriasis versus control |
Psoriatic arthritis versus psoriasis without arthritis |
| | Age (years), M ± SD | 46.4 ± 14.1 | 48.0 ± 10.6 | 45.5 ± 15.8 | 45.7 ± 11.3 | 0.516 | 0.846 | | Sex-male, ; % | 61; 100.00 | 22; 100.00 | 39; 100.00 | 30; 100.00 | — | — | | Duration of psoriasis (years), M ± SD | 20.8 ± 12.0 | 23.7 ± 9.0 | 19.1 ± 13.3 | — | — | 0.153 | | Duration of psoriatic arthritis (years), M ± SD | — | 10.1 ± 6.2 | — | — | — | | | Positive family history of psoriasis, ; % | 21; 34.43 | 7; 31.82 | 14; 35.89 | — | — | 0.747 | | PASI, M ± SD | 23.1 ± 12.0 | 21.3 ± 9.1 | 24.2 ± 13.4 | — | — | 0.366 | | BSA (%), M ± SD | 27.6 ± 20.6 | 25.1 ± 15.6 | 29.0 ± 23.0 | — | — | 0.484 | | PGA, , % | | | | — |
— |
0.168 | | 2 | 10; 16.39 | 2; 9.09 | 8; 20.51 | — | | 3 | 34; 55.74 | 15; 68.18 | 19; 48.72 | — | | 4 | 12; 19.67 | 5; 22.73 | 7; 17.95 | — | | 5 | 5; 8.20 | 0; 0.00 | 5; 12.82 | — |
|
|
